申请人:SANTEN PHARMACEUTICAL CO., LTD.
公开号:EP0639566A1
公开(公告)日:1995-02-22
This invention offers novel compounds of the formula [I] which are useful for treatment or various immune diseases such as immunodeficiency and autoimmune disease, caused by immuno disorders, and synthetic intermediates thereof represented by the formula [II],
wherein
R¹ and R² are the same or different and each is hydrogen or lower alkyl;
R³ and R⁴ are the same or different and each is hydrogen, lower alkyl, carboxy or lower alkoxycarbonyl;
R⁵ and R⁶ are the same or different and each is hydrogen, lower alkyl, lower alkenyl, lower alkanoyl, (substituted) phenyl lower alkyl, (substituted) phenylcarbonyl, trityl or tetrahydropyranyl;
X is oxygen or NR⁷;
R⁷ is hydrogen, (substituted) lower alkyl, lower alkoxy, (substituted) phenyl lower alkyl or (substituted) phenyl lower alkoxy, and
A is straight or branched lower alkylene.
本发明提供了可用于治疗由免疫紊乱引起的各种免疫疾病(如免疫缺陷和自身免疫疾病)的式[I]新型化合物,以及由式[II]表示的其合成中间体、
其中
R¹ 和 R² 相同或不同,各自为氢或低级烷基;
R³ 和 R⁴ 相同或不同,各自为氢、低级烷基、羧基或低级烷氧基羰基;
R⁵ 和 R⁶ 相同或不同,各自为氢、低级烷基、低级烯基、低级烷酰基、(取代的)苯基低级烷基、(取代的)苯基羰基、三苯甲基或四氢吡喃基;
X 是氧或 NR⁷;
R⁷ 是氢、(取代的)低级烷基、低级烷氧基、(取代的)苯基低级烷基或 (取代的)苯基低级烷氧基,以及
A 是直链或支链低级亚烷基。